Development Targeting Claudin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development Targeting Claudin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Targeting Claudin Today - Breaking & Trending Today

Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual Meeting

Published: November 3, 2023

Research Provides Early Validation of ALLO-182, an AlloCAR T™ Candidate in the IND-Enabling Phase of Development Targeting Claudin18.2 for the Treatment of Patients with Gastric and Pancreatic...

Source: marketscreener.com

Related Topics:

South San FranciscoUnited StatesSan DiegoMadeleine GoldsteinZachary RobertsChristine CassianoAllogene AlloLeslie BryantCorporate Affairs Brand StrategyAllogene Therapeutics IncResearch Provides Early ValidationSociety For Immunotherapy Of CancerResearch DevelopmentPhase Of Development Targeting ClaudinEnabling PhaseDevelopment Targeting ClaudinAnnual Meeting NovemberExecutive Vice PresidentChief Medical OfficerForward Looking StatementsPrivate Securities Litigation Reform ActAllogene TherapeuticsInvestor ContactAllogene Media Contacts